VDRM — Viaderma Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.25m
- $4.97m
- $0.45m
Annual balance sheet for Viaderma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2009 December 31st | 2010 December 31st | 2011 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.777 | 0.973 | 0.578 | 0.01 | 0.012 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 14.7 | 14.4 | 13.6 | 1.27 | 0.004 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 15.9 | 15.8 | 14.8 | 1.28 | 3.55 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 13.9 | 19.7 | 26.7 | — | — |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 30 | 36.1 | 42.6 | 1.28 | 3.56 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.52 | 5.81 | 5.77 | 1.16 | 7.3 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 6.6 | 6.87 | 9.09 | 1.16 | 7.3 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 23.5 | 29.2 | 33.6 | 0.123 | -3.74 |
Total Liabilities & Shareholders' Equity | 30 | 36.1 | 42.6 | 1.28 | 3.56 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |